CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 24 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,275 | -39.9% | 3,591 | -0.4% | 0.00% | – |
| Q2 2023 | $2,123 | +106050.0% | 3,605 | -1.0% | 0.00% | – |
| Q1 2023 | $2 | +100.0% | 3,641 | +63.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 2,234 | +156.5% | 0.00% | – |
| Q3 2022 | $1,000 | -83.3% | 871 | -84.0% | 0.00% | – |
| Q2 2022 | $6,000 | -40.0% | 5,442 | +62.1% | 0.00% | – |
| Q1 2022 | $10,000 | +900.0% | 3,358 | +1579.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 200 | -14.2% | 0.00% | – |
| Q2 2021 | $1,000 | -75.0% | 233 | -62.7% | 0.00% | – |
| Q1 2021 | $4,000 | +300.0% | 624 | +670.4% | 0.00% | – |
| Q4 2020 | $1,000 | – | 81 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 462,659 | $1,411,000 | 0.58% |
| Sio Capital Management, LLC | 422,598 | $1,289,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $1,550,000 | 0.22% |
| Affinity Asset Advisors, LLC | 400,000 | $1,220,000 | 0.20% |
| Atom Investors LP | 31,385 | $96,000 | 0.04% |
| Ikarian Capital, LLC | 104,741 | $319,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 514,780 | $1,570,000 | 0.01% |
| PURA VIDA INVESTMENTS, LLC | 77,568 | $237,000 | 0.01% |
| Point72 Asset Management, L.P. | 230,000 | $702,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 58,934 | $179,000 | 0.00% |